About the Opportunity
The Jagiellonian University in Kraków, Poland, in collaboration with several global academic and industry partners, has launched the MAP-ID PhD program (Multilevel Approaches to Understanding Chronic Inflammatory Diseases), co-funded by the European Commission’s Horizon Europe Marie Skłodowska-Curie COFUND scheme.
This is an outstanding opportunity for aspiring PhD researchers looking to work at the intersection of immunology, biotechnology, and bioinformatics while gaining international experience across Europe and the USA.
Key Highlights
- Total Positions: 13 fully funded PhD positions
- Program Duration: 48 months
- Start Dates:
- First Call: October 1, 2025
- Second Call (if applicable): March 1, 2026
- Stipend: €2,800/month gross (~€1,700/month net)
- Benefits: Full-time employment with social security, health, and pension coverage
- Secondments:
- 6–9 months at partner universities in Europe/USA
- 3 months at European biotech companies
Partner Institutions
Academic Collaborators (Europe & USA):
- KU Leuven, Belgium
- University of Oxford, UK
- University Hospital Zurich, Switzerland
- Sapienza University of Rome, Italy
- Medical University of Graz, Austria
- University of Nevada Las Vegas, USA
- University of Groningen, Netherlands
- University of Pavia, Italy
- Bellvitge Biomedical Research Institute, Spain
- Universitat de Vic – Universitat Central de Catalunya, Spain
- West Virginia University, USA
- Virginia Commonwealth University, USA
Biotech Industry Partners:
- Ryvu Therapeutics
- WPD Pharmaceuticals
- IntoDNA
- BGI Tech Solutions
- Scope-Fluidics
- Cambridge Protein Works
- Polish Stem Cell Bank
- Bacteromic
- PerioTrap
Research Projects Overview
Each PhD position is linked to one of these cutting-edge projects:
- Role of RNase Regnase-2 in glioblastoma progression
- Inflammation in renal and liver cancer
- Tumor redox response to immunotherapy
- Fibroblasts in immune responses
- Immune-nervous system crosstalk
- Epigenetic memory of hematopoietic stem cells
- Transcriptome regulation via PIN RNases
- Periodontitis–rheumatoid arthritis molecular link
- Bacterial diseases in renal carcinoma
- Antibiotic resistance in S. aureus
- Stem cell-derived vesicles for tissue repair
- Receptors in innate immunity
- Small RNAs in wound healing
Eligibility Criteria
- Education: Master’s degree in Biology, Biotechnology, Biochemistry, Medicine, or related field
- PhD Status: Must not already hold a PhD
- Mobility Rule: Must not have resided or worked in Poland for more than 12 of the last 36 months
- English Proficiency: Minimum level B2
Application Timeline
- First Call:
- Opens: April 28, 2025
- Closes: June 30, 2025
- Second Call (if required):
- Opens: September 1, 2025
- Closes: November 2, 2025
All applications must be submitted through the IRK system.
How to Apply
- Visit the official program website: https://cofund.project.uj.edu.pl/
- Review all 13 projects and select your preferred one(s)
- Prepare required documents (CV, motivation letter, academic transcripts, etc.)
- Submit via the online IRK portal before the deadline
Contact for Queries
Email: cofund_mapid@uj.edu.pl
Why You Should Apply
This program offers a rare mix of:
- Prestigious MSCA funding
- Access to international academic and industry networks
- Hands-on training in chronic inflammation research
- Long-term mobility and career development support
Whether you’re aiming for an academic, clinical, or biotech career, MAP-ID offers a strong foundation in high-impact biomedical research.
🔗 Visit our website for more global PhD, postdoc, and fellowship opportunities in life sciences, bioinformatics, and drug design:
www.biocareershub.com